MYCN and neuroblastoma: According to the degree of tumor cell differentiation, presence or absence of stroma, mitotic nuclear rupture index, patient age, histological type, MYCN oncogene status, DNA ploidy, and chromosome 11q status, NB patients were classified as very low risk, low risk, intermediate risk, or high risk, respectively (Valter et al., 2018).